GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism - Université de Bourgogne Accéder directement au contenu
Article Dans Une Revue Trends in Endocrinology and Metabolism = Trends in Endocrinology & Metabolism Année : 2021

GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic of respiratory and cardiovascular diseases, known as coronavirus disease 2019 (COVID-19). SARS-CoV-2 encodes the structural proteins spike (S), envelope (E), membrane (M), and nucleocapsid (N). The receptor-binding domain on the surface subunit S1 is responsible for attachment of the virus to angiotensin (Ang)-converting enzyme 2 (ACE2), which is highly expressed in host cells. The cytokine storm observed in patients with COVID-19 contributes to the endothelial vascular dysfunction, which can lead to acute respiratory distress syndrome, multiorgan failure, alteration in iron homeostasis, and death. Growth and differentiation factor 15 (GDF15), which belongs to the transforming growth factor-β (TGF-β) superfamily of proteins, has a pivotal role in the development and progression of diseases because of its role as a metabolic regulator. In COVID-19, GDF15 activity increases in response to tissue damage. GDF15 appears to be a strong predictor of poor outcomes in patients critically ill with COVID-19 and acts as an ‘inflammation-induced central mediator of tissue tolerance’ via its metabolic properties. In this review, we examine the potential properties of GDF15 as an emerging modulator of immunity in COVID-19 in association with iron metabolism. The virus life cycle in host cell provides potential targets for drug therapy.
Fichier principal
Vignette du fichier
main.pdf (2.13 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03413412 , version 1 (03-11-2021)

Identifiants

Citer

Luc Rochette, Marianne Zeller, Yves Cottin, Catherine Vergely. GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism. Trends in Endocrinology and Metabolism = Trends in Endocrinology & Metabolism , 2021, 32 (11), pp.875-889. ⟨10.1016/j.tem.2021.08.011⟩. ⟨hal-03413412⟩
47 Consultations
129 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More